Browse

Explore conditions, clinical trials, and the organisations running them.

Conditions By category Trials Sponsors

← All categories

Up to: Disease susceptibility

Inherited disease susceptibility

A latent susceptibility to disease at the genetic level, which may be activated under certain conditions.

81 trials tagged with this condition →

Hereditary neoplastic syndrome 60 trials · 731 incl. sub-types Sub-types →
Diabetes mellitus, insulin-dependent, X-linked, susceptibility to 0 trials · 178 incl. sub-types Sub-types →
Lumbar disk herniation, susceptibility to 96 trials
Urinary tract infections, recurrent, susceptibility to 40 trials
Osteoarthritis susceptibility 6 37 trials
Pregnancy loss, recurrent, susceptibility 21 trials · 32 incl. sub-types Sub-types →
Osteoarthritis susceptibility 2 16 trials
IgA nephropathy, susceptibility to 0 trials · 16 incl. sub-types Sub-types →
Essential hypertension, genetic 14 trials
Osteoarthritis susceptibility 5 14 trials
Polysubstance abuse, susceptibility to 10 trials
Osteoarthritis susceptibility 1 8 trials
Autism, susceptiblity to 0 trials · 8 incl. sub-types Sub-types →
Focal segmental glomerulosclerosis 4, susceptibility to 7 trials
GBA1-related Parkinson disease, susceptibility 6 trials
Neural tube defects, susceptibility to 6 trials
Otitis media, susceptibility to 5 trials
Pulmonary edema of mountaineers, susceptibility to 5 trials
Exfoliation syndrome, susceptibility to 4 trials
Pelvic organ prolapse, susceptibility to 4 trials
Inherited susceptibility to asthma 2 trials · 3 incl. sub-types Sub-types →
Breast-ovarian cancer, familial, susceptibility to 0 trials · 3 incl. sub-types Sub-types →
Diabetes mellitus, ketosis-prone 2 trials
Microvascular complications of diabetes, susceptibility 2 trials Sub-types →
Alzheimer disease 9 1 trial
Helicobacter pylori infection, susceptibility to 1 trial
UV-induced skin damage, susceptibility to 1 trial
Antisocial behavior, susceptibility to 1 trial
Autosomal recessive mendelian susceptibility to mycobacterial diseases due to partial jak1 deficiency 1 trial
Coronary artery disease, severe, susceptibility to 1 trial
Familial meningioma 1 trial
Hearing loss, cisplatin-induced, susceptibility to 1 trial
Hemorrhage, intracerebral, susceptibility to 1 trial
Hepatic fibrosis, severe, susceptibility to, due to Schistosoma mansoni infection 1 trial
Hepatitis C virus, susceptibility to 1 trial
Inherited susceptibility to mycobacterial diseases 1 trial Sub-types →
Nephrolithiasis, uric acid, susceptibility to 1 trial
Predisposition to invasive fungal disease due to CARD9 deficiency 1 trial
Tobacco addiction, susceptibility to 1 trial
Alzheimer disease, susceptibility to, mitochondrial 0 trials
Ascaris lumbricoides infection, susceptibility to 0 trials
Asperger syndrome, susceptibility to 0 trials Sub-types →
Buruli ulcer, susceptibility to 0 trials
Graves disease, susceptibility to, 1 0 trials
Graves disease, susceptibility to, X-linked 2 0 trials
Hirschsprung disease, susceptibility to 0 trials Sub-types →
Leber optic atrophy, susceptibility to 0 trials
Mycobacterium tuberculosis, susceptibility 0 trials Sub-types →
Parkinson disease 11, autosomal dominant, susceptibility to 0 trials
Parkinson disease 13, autosomal dominant, susceptibility to 0 trials
Parkinson disease 18, autosomal dominant, susceptibility to 0 trials
Parkinson disease 24, autosomal dominant, susceptibility to 0 trials
Parkinson disease 26, autosomal dominant, susceptibility to 0 trials
Parkinson disease 5, autosomal dominant, susceptibility to 0 trials
SH2B3-related immune system disorder 0 trials
Schistosoma mansoni infection, susceptibility/resistance to 0 trials
West Nile virus, susceptibility to 0 trials
Age related macular degeneration, susceptibility to 0 trials Sub-types →
Allergic rhinitis, susceptibility to 0 trials
Amyotrophic lateral sclerosis, susceptibility to, 13 0 trials
Amyotrophic lateral sclerosis, susceptibility to, 24 0 trials
Amyotrophic lateral sclerosis, susceptibility to, 25 0 trials
Anorexia nervosa, susceptibility to, 1 0 trials
Aortic aneurysm, familial thoracic 11, susceptibility to 0 trials
Aplastic anemia, susceptibility to 0 trials
Appendicitis, proneness to 0 trials
Aspergillosis, susceptibility to 0 trials
Atherosclerosis susceptibility 0 trials
Atrioventricular septal defect, susceptibility to, 1 0 trials
Atrioventricular septal defect, susceptibility to, 2 0 trials
Attention deficit-hyperactivity disorder, susceptibility to, 1 0 trials
Attention deficit-hyperactivity disorder, susceptibility to, 2 0 trials
Attention deficit-hyperactivity disorder, susceptibility to, 3 0 trials
Attention deficit-hyperactivity disorder, susceptibility to, 4 0 trials
Attention deficit-hyperactivity disorder, susceptibility to, 5 0 trials
Attention deficit-hyperactivity disorder, susceptibility to, 6 0 trials
Attention deficit-hyperactivity disorder, susceptibility to, 7 0 trials
Autoimmune disease, susceptibility to, 1 0 trials
Autoimmune disease, susceptibility to, 2 0 trials
Autoimmune disease, susceptibility to, 3 0 trials
Autoimmune disease, susceptibility to, 4 0 trials
Autoimmune disease, susceptibility to, 5 0 trials
Autoimmune disease, susceptibility to, 6 0 trials
Autoimmune thyroid disease, susceptibility to 0 trials Sub-types →
Autoimmune thyroid disease, susceptibility to, 5 0 trials
Autosomal recessive Mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR1 deficiency 0 trials
Autosomal recessive Mendelian susceptibility to mycobacterial diseases due to partial IFNgammaR2 deficiency 0 trials
Bacteremia, susceptibility 0 trials Sub-types →
Basal cell carcinoma, susceptibility to 0 trials Sub-types →
Bleeding disorder, platelet-type, 13, susceptibility to 0 trials
Blepharospasm, benign essential, susceptibility to 0 trials
Bulimia nervosa, susceptibility to, 1 0 trials
Cardiomyopathy, familial hypertrophic, 4, susceptibility to 0 trials
Celiac disease, susceptibility to, 1 0 trials
Celiac disease, susceptibility to, 10 0 trials
Celiac disease, susceptibility to, 11 0 trials
Celiac disease, susceptibility to, 12 0 trials
Celiac disease, susceptibility to, 13 0 trials
Celiac disease, susceptibility to, 2 0 trials
Celiac disease, susceptibility to, 3 0 trials
Celiac disease, susceptibility to, 4 0 trials
Celiac disease, susceptibility to, 5 0 trials
Celiac disease, susceptibility to, 6 0 trials
Celiac disease, susceptibility to, 7 0 trials
Celiac disease, susceptibility to, 8 0 trials
Celiac disease, susceptibility to, 9 0 trials
Chronic mountain sickness, susceptibility to 0 trials
Cirrhosis, noncryptogenic, susceptibility to 0 trials
Coronary heart disease, susceptibility to, 1 0 trials
Coronary heart disease, susceptibility to, 2 0 trials
Coronary heart disease, susceptibility to, 3 0 trials
Coronary heart disease, susceptibility to, 4 0 trials
Coronary heart disease, susceptibility to, 5 0 trials
Coronary heart disease, susceptibility to, 6 0 trials
Coronary heart disease, susceptibility to, 7 0 trials
Coronary heart disease, susceptibility to, 8 0 trials
Coronary heart disease, susceptibility to, 9 0 trials
Craniosynostosis 5, susceptibility to 0 trials
Craniosynostosis 7 0 trials
Delayed sleep phase syndrome, susceptibility to 0 trials
Dengue fever, susceptibility to 0 trials
Dengue hemorrhagic fever, susceptibility to 0 trials
Dengue shock syndrome, susceptibility to 0 trials
Dengue virus, susceptibility to 0 trials
Dermatitis, atopic, susceptibility to 0 trials Sub-types →
Dyslexia, susceptibility to, 1 0 trials
Dyslexia, susceptibility to, 2 0 trials
Dyslexia, susceptibility to, 3 0 trials
Dyslexia, susceptibility to, 4 0 trials
Dyslexia, susceptibility to, 5 0 trials
Dyslexia, susceptibility to, 6 0 trials
Dyslexia, susceptibility to, 7 0 trials
Dyslexia, susceptibility to, 8 0 trials
Dyslexia, susceptibility to, 9 0 trials
Dystonia 38, susceptibility to 0 trials
Efavirenz central nervous system toxicity, susceptibility to 0 trials
Encephalitis, acute, infection-induced, susceptibility to 0 trials Sub-types →
Endometriosis, susceptibility to, 1 0 trials
Epidermodysplasia verruciformis, susceptibility to 0 trials Sub-types →
Epilepsy, childhood absence, susceptibility to, 1 0 trials
Epilepsy, childhood absence, susceptibility to, 5 0 trials
Epilepsy, childhood absence, susceptibility to, 6 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 1 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 10 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 12 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 13 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 14 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 15 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 16 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 17 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 18 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 19 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 2 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 3 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 4 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 5 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 6 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 7 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 8 0 trials
Epilepsy, idiopathic generalized, susceptibility to, 9 0 trials
Epilepsy, juvenile absence, susceptibility to 0 trials Sub-types →
Epilepsy, juvenile myoclonic, susceptibility to, 10 0 trials
Epilepsy, juvenile myoclonic, susceptibility to, 6 0 trials
Epilepsy, juvenile myoclonic, susceptibility to, 9 0 trials
Fatty liver disease, nonalcoholic, susceptibility to, 2 0 trials
Focal segmental glomerulosclerosis 3, susceptibility to 0 trials
Gallbladder disease 4 0 trials
Glaucoma, normal tension, susceptibility to 0 trials
Graft-versus-host disease, susceptibility to 0 trials
Hearing loss, noise-induced, susceptibility to 0 trials
Hemolytic uremic syndrome, atypical, susceptibility to, 1 0 trials Sub-types →
Hemolytic uremic syndrome, atypical, susceptibility to, 7 0 trials
Hepatitis B virus, susceptibility to 0 trials
Hepatitis, fulminant viral, susceptibility to 0 trials
Herpes simplex encephalitis, susceptibility to, 1 0 trials
Herpes simplex encephalitis, susceptibility to, 2 0 trials
Herpes simplex encephalitis, susceptibility to, 3 0 trials
Herpes simplex encephalitis, susceptibility to, 4 0 trials
Herpes simplex encephalitis, susceptibility to, 7 0 trials
Human herpesvirus 8, susceptibility to 0 trials
Hydrocephalus, congenital, 5, susceptibility to 0 trials
Hyperemesis gravidarum, susceptibility to 0 trials
Hyperlipidemia, combined, 1 0 trials
Hypertension, essential, susceptibility to, 1 0 trials
Hypertension, essential, susceptibility to, 2 0 trials
Hypertension, essential, susceptibility to, 3 0 trials
Hypertension, essential, susceptibility to, 4 0 trials
Hypertension, essential, susceptibility to, 5 0 trials
Hypertension, essential, susceptibility to, 6 0 trials
Hypertension, essential, susceptibility to, 7 0 trials
Hypertension, essential, susceptibility to, 8 0 trials
Hypervitaminosis a, susceptibility to 0 trials
Influenza, severe, susceptibility to 0 trials
Iron overload, susceptibility to 0 trials
Kuru, susceptibility to 0 trials
Legionnaire disease, susceptibility to 0 trials
Leishmaniasis, tegumentary, susceptibility to 0 trials
Leprosy, susceptibility to, 1 0 trials
Leprosy, susceptibility to, 2 0 trials
Leprosy, susceptibility to, 3 0 trials
Leprosy, susceptibility to, 4 0 trials
Leprosy, susceptibility to, 5 0 trials
Leprosy, susceptibility to, 6 0 trials
Lipodystrophy, partial, acquired, susceptibility to 0 trials
Lumbar disk degeneration, susceptibility to 0 trials
Major depressive disorder 1 0 trials
Major depressive disorder 2 0 trials
Malaria, susceptibility to 0 trials Sub-types →
Malignant hyperthermia, susceptibility to 0 trials Sub-types →
Melioidosis, susceptibility to 0 trials
Migraine with or without aura, susceptibility to 0 trials Sub-types →
Multicentric Castleman disease, susceptibility to 0 trials
Multiple sclerosis, susceptibility to 0 trials Sub-types →
Multiple system atrophy 1, susceptibility to 0 trials
Myocardial infarction, susceptibility to 0 trials
Myocardial infarction, susceptibility to, 2 0 trials
Myoclonic epilepsy, juvenile, susceptibility to, 1 0 trials
Myoclonic epilepsy, juvenile, susceptibility to, 3 0 trials
Myoclonic epilepsy, juvenile, susceptibility to, 4 0 trials
Narcolepsy, susceptibility to 0 trials Sub-types →
Nephrolithiasis susceptibility caused by SLC26A1 0 trials
Nonarteritic anterior ischemic optic neuropathy, susceptibility to 0 trials
Obesity, susceptibility to 0 trials
Opioid dependence, susceptibility to, 1 0 trials
Orofacial cleft 6, susceptibility to 0 trials
Osteoarthritis susceptibility 3 0 trials
Osteoarthritis susceptibility 4 0 trials
Pelvic organ prolapse, susceptibility to, 1 0 trials
Pelvic organ prolapse, susceptibility to, 2 0 trials
Peripartum cardiomyopathy, susceptibility to 0 trials
Podoconiosis, susceptibility to 0 trials
Polycystic kidney disease 9, susceptibility to 0 trials
Psoriasis, susceptibility to 0 trials Sub-types →
Psoriatic arthritis, susceptibility to 0 trials Sub-types →
Pulmonary disease, chronic obstructive, susceptibility to 0 trials
Pulmonary hypertension, neonatal, susceptibility to 0 trials
Radioulnar synostosis, nonsyndromic, susceptibility to 0 trials
Renal dysplasia, cystic, susceptibility to 0 trials
Restless legs syndrome, susceptibility to 0 trials Sub-types →
Rhabdomyolysis, susceptibility to 0 trials Sub-types →
Sarcoidosis, susceptibility to, 1 0 trials
Sarcoidosis, susceptibility to, 2 0 trials
Sarcoidosis, susceptibility to, 3 0 trials
Schizophrenia, susceptibility to 0 trials Sub-types →
Scoliosis, isolated, susceptibility to 0 trials Sub-types →
Seasonal affective disorder, susceptibility to 0 trials
Sick sinus syndrome 3, susceptibility to 0 trials
Spondyloarthropathy, susceptibility to 0 trials Sub-types →
Strabismus, susceptibility to 0 trials Sub-types →
Stroke, susceptibility to, 1 0 trials
Susceptibility to HIV infection 0 trials
Susceptibility to angioedema induced by ACE inhibitors 0 trials
Susceptibility to localized juvenile periodontitis 0 trials
Susceptibility to mononeuropathy of the median nerve, mild 0 trials
Susceptibility to respiratory infections associated with CD8alpha chain mutation 0 trials
Susceptibility to visceral leishmaniasis, 1 0 trials
Susceptibility to visceral leishmaniasis, 2 0 trials
Susceptibility to visceral leishmaniasis, 3 0 trials
Systemic lupus erythematosus with hemolytic anemia, susceptibility to, 1 0 trials
Systemic lupus erythematosus with nephritis, susceptibility to, 1 0 trials
Systemic lupus erythematosus with nephritis, susceptibility to, 2 0 trials
Systemic lupus erythematosus with nephritis, susceptibility to, 3 0 trials
Systemic lupus erythematosus, susceptibility to, 1 0 trials
Systemic lupus erythematosus, susceptibility to, 10 0 trials
Systemic lupus erythematosus, susceptibility to, 11 0 trials
Systemic lupus erythematosus, susceptibility to, 12 0 trials
Systemic lupus erythematosus, susceptibility to, 13 0 trials
Systemic lupus erythematosus, susceptibility to, 14 0 trials
Systemic lupus erythematosus, susceptibility to, 15 0 trials
Systemic lupus erythematosus, susceptibility to, 2 0 trials
Systemic lupus erythematosus, susceptibility to, 3 0 trials
Systemic lupus erythematosus, susceptibility to, 4 0 trials
Systemic lupus erythematosus, susceptibility to, 5 0 trials
Systemic lupus erythematosus, susceptibility to, 6 0 trials
Systemic lupus erythematosus, susceptibility to, 7 0 trials
Systemic lupus erythematosus, susceptibility to, 8 0 trials
Systemic lupus erythematosus, susceptibility to, 9 0 trials
Thyrotoxic periodic paralysis, susceptibility to, 1 0 trials
Thyrotoxic periodic paralysis, susceptibility to, 2 0 trials
Thyrotoxic periodic paralysis, susceptibility to, 3 0 trials
Ventricular fibrillation during myocardial infarction, susceptibility to 0 trials
Vitiligo-associated multiple autoimmune disease susceptibility 1 0 trials
Vitiligo-associated multiple autoimmune disease susceptibility 6 0 trials
Xanthomatosis, susceptibility to 0 trials